By Josh Beckerman An Intercept Pharmaceuticals Inc. drug received two unfavorable votes from a Food and Drug Administration advisory committee. Intercept shares were halted...
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING...
(Data below is sourced from the Virtus website unless otherwise stated.) Fund History The Virtus Total Return Fund (NYSE:ZTR) was originally created in 2005,...
Last October, about 50 activists gathered outside a luxury apartment in Manhattan belonging to Evan Greenberg, CEO of insurance giant Chubb. The group delivered...